What are the benefits of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease?
A post hoc analysis of the Treating to New Targets (TNT) study found that atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease has potential benefits. These benefits include reduced risk for cardiovascular events, improved lipid profiles, and improved response to statin therapy. Additionally, a meta-analysis of randomized controlled trials found that N-3 polyunsaturated fatty acids have a positive effect on coronary heart disease. Furthermore, according to the American Heart Association, a diet high in fish consumption and/or fish oil omega-3 fatty acids can help reduce the risk of cardiovascular disease in women.  